145 related articles for article (PubMed ID: 37845450)
1. The Impact of Heterogeneous Cell Density in Hypoxic Tumors Treated with Radiotherapy.
Schiavo F; Toma-Dasu I; Kjellsson Lindblom E
Adv Exp Med Biol; 2023; 1438():121-126. PubMed ID: 37845450
[TBL] [Abstract][Full Text] [Related]
2. Volume effects in the TCP for hypoxic and oxygenated tumors.
Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
[TBL] [Abstract][Full Text] [Related]
3. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.
Espinoza I; Peschke P; Karger CP
Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250
[TBL] [Abstract][Full Text] [Related]
4. Towards the virtual tumor for optimizing radiotherapy treatments of hypoxic tumors: A novel model of heterogeneous tissue vasculature and oxygenation.
Schiavo F; Kjellsson Lindblom E; Toma-Dasu I
J Theor Biol; 2022 Aug; 547():111175. PubMed ID: 35644483
[TBL] [Abstract][Full Text] [Related]
5. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.
Antonovic L; Lindblom E; Dasu A; Bassler N; Furusawa Y; Toma-Dasu I
J Radiat Res; 2014 Sep; 55(5):902-11. PubMed ID: 24728013
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Induced by Vascular Damage at High Doses Could Compromise the Outcome of Radiotherapy.
Lindblom EK; Dasu A; Toma-Dasu I
Anticancer Res; 2019 May; 39(5):2337-2340. PubMed ID: 31092425
[TBL] [Abstract][Full Text] [Related]
7. To fractionate or not to fractionate? That is the question for the radiosurgery of hypoxic tumors.
Toma-Dasu I; Sandström H; Barsoum P; Dasu A
J Neurosurg; 2014 Dec; 121 Suppl():110-5. PubMed ID: 25434944
[TBL] [Abstract][Full Text] [Related]
8. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
Ruggieri R; Nahum AE
Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia dose painting in SBRT - the virtual clinical trial approach.
Schiavo F; Toma-Dasu I; Kjellsson Lindblom E
Acta Oncol; 2023 Oct; 62(10):1239-1245. PubMed ID: 37713263
[TBL] [Abstract][Full Text] [Related]
10. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
[TBL] [Abstract][Full Text] [Related]
11. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
12. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.
Popple RA; Ove R; Shen S
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):921-7. PubMed ID: 12377346
[TBL] [Abstract][Full Text] [Related]
13. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
[TBL] [Abstract][Full Text] [Related]
14. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
15. Accounting for Two Forms of Hypoxia for Predicting Tumour Control Probability in Radiotherapy: An In Silico Study.
Lindblom E; Toma-Dasu I; Dasu A
Adv Exp Med Biol; 2018; 1072():183-187. PubMed ID: 30178343
[TBL] [Abstract][Full Text] [Related]
16. Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
South CP; Evans PM; Partridge M
Med Phys; 2009 Oct; 36(10):4379-88. PubMed ID: 19928068
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced Vascular Damage and the Impact on the Treatment Outcome of Stereotactic Body Radiotherapy.
Lindblom EK; Hui S; Brooks J; Dasu A; Kujawski M; Toma-Dasu I
Anticancer Res; 2019 Jun; 39(6):2721-2727. PubMed ID: 31177107
[TBL] [Abstract][Full Text] [Related]
18. Radiation response of hypoxic and generally heterogeneous tissues.
Nilsson J; Lind BK; Brahme A
Int J Radiat Biol; 2002 May; 78(5):389-405. PubMed ID: 12020429
[TBL] [Abstract][Full Text] [Related]
19. Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.
Wulbrand C; Seidl C; Gaertner FC; Bruchertseifer F; Morgenstern A; Essler M; Senekowitsch-Schmidtke R
PLoS One; 2013; 8(5):e64730. PubMed ID: 23724085
[TBL] [Abstract][Full Text] [Related]
20. Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions.
Khalil AA; Bentzen SM; Overgaard J
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):797-802. PubMed ID: 9369125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
